MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells

Alba Rocco, Debora Compare, Eleonora Liguori, Alessandra Cianflone, Giuseppe Pirozzi, Virginia Tirino, Alessandra Bertoni, Margherita Santoriello, Corrado Garbi, Maria D'Armiento, Stefania Staibano, Gerardo Nardone

Research output: Contribution to journalArticle

Abstract

P-glycoprotein (P-gp), traditionally linked to cancer poor prognosis and multidrug resistance, is undetectable in normal gastric mucosa and overexpressed in gastric cancer (GC). We propose that P-gp may be involved in Helicobacter pylori (Hp)-related gastric carcinogenesis by inhibiting apoptosis. Aim of the study was to evaluate the expression of P-gp in fetal stomach and in Hp-related gastric carcinogenesis, the epigenetic control of the multi-drug resistance-1 (MDR1) gene, the localization and interaction between P-gp and Bcl-x L and the effect of the selective silencing of P-gp on cell survival. P-gp and Bcl-xl expression was evaluated by immunohistochemistry on 28 spontaneously abortive human fetuses, 66 Hp-negative subjects, 138 Hp-positive chronic gastritis (CG) of whom 28 with intestinal metaplasia (IM) and 45 intestinal type GCs. P-gp/Bcl-x L colocalization was investigated by confocal immunofluorescence microscopy and protein-protein interaction by co-immunoprecipitation, in basal conditions and after stress-induced apoptosis, in GC cell lines AGS and MKN-28 and hepatocellular carcinoma cell line Hep-G2. The role of P-gp in controlling apoptosis was evaluated by knocking down its expression with a specific small interfering RNAs in stressed AGS and MKN-28 cell lines. P-gp is expressed in the gastric mucosa of all human fetuses while, it is undetectable in adult normal mucosa and re-expressed in 30/110 Hp-positive non-IM-CG, 28/28 IM-CG and 40/45 GCs. P-gp expression directly correlates with that of Bcl-x L and with the promoter hypomethylation of the MDR1 gene. In GC cell lines, P-gp is localized on the plasma membrane and mitochondria where it colocalizes with Bcl-x L. Co-immunoprecipitation confirms the physical interaction between P-gp and Bcl-x L in AGS, MKN-28 and Hep-G2, at both basal level and after stress-induced apoptosis. The selective silencing of P-gp sensitizes GC cells to stress-induced apoptosis. P-gp behaves as an oncofetal protein that, by cross-talking with Bcl-x L, acts as an anti-apoptotic agent in Hp-related gastric carcinogenesis.

Original languageEnglish
Pages (from-to)1407-1418
Number of pages12
JournalLaboratory Investigation
Volume92
Issue number10
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Multiple Drug Resistance
P-Glycoprotein
Stomach Neoplasms
Cell Survival
Helicobacter pylori
Apoptosis
Stomach
Metaplasia
Gastritis
Carcinogenesis
Gastric Mucosa
P-glycoprotein 2
oncofetal antigens
Immunoprecipitation
Cell Line
Fetus
Hep G2 Cells
Fluorescence Microscopy
Epigenomics
Confocal Microscopy

Keywords

  • apoptosis
  • gastric carcinogenesis
  • H. pylori
  • P-glycoprotein
  • stomach morphogenesis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology

Cite this

Rocco, A., Compare, D., Liguori, E., Cianflone, A., Pirozzi, G., Tirino, V., ... Nardone, G. (2012). MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells. Laboratory Investigation, 92(10), 1407-1418. https://doi.org/10.1038/labinvest.2012.100

MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells. / Rocco, Alba; Compare, Debora; Liguori, Eleonora; Cianflone, Alessandra; Pirozzi, Giuseppe; Tirino, Virginia; Bertoni, Alessandra; Santoriello, Margherita; Garbi, Corrado; D'Armiento, Maria; Staibano, Stefania; Nardone, Gerardo.

In: Laboratory Investigation, Vol. 92, No. 10, 10.2012, p. 1407-1418.

Research output: Contribution to journalArticle

Rocco, A, Compare, D, Liguori, E, Cianflone, A, Pirozzi, G, Tirino, V, Bertoni, A, Santoriello, M, Garbi, C, D'Armiento, M, Staibano, S & Nardone, G 2012, 'MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells', Laboratory Investigation, vol. 92, no. 10, pp. 1407-1418. https://doi.org/10.1038/labinvest.2012.100
Rocco, Alba ; Compare, Debora ; Liguori, Eleonora ; Cianflone, Alessandra ; Pirozzi, Giuseppe ; Tirino, Virginia ; Bertoni, Alessandra ; Santoriello, Margherita ; Garbi, Corrado ; D'Armiento, Maria ; Staibano, Stefania ; Nardone, Gerardo. / MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells. In: Laboratory Investigation. 2012 ; Vol. 92, No. 10. pp. 1407-1418.
@article{9f1dad60bcbc44b1a07802e4e4576dd7,
title = "MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells",
abstract = "P-glycoprotein (P-gp), traditionally linked to cancer poor prognosis and multidrug resistance, is undetectable in normal gastric mucosa and overexpressed in gastric cancer (GC). We propose that P-gp may be involved in Helicobacter pylori (Hp)-related gastric carcinogenesis by inhibiting apoptosis. Aim of the study was to evaluate the expression of P-gp in fetal stomach and in Hp-related gastric carcinogenesis, the epigenetic control of the multi-drug resistance-1 (MDR1) gene, the localization and interaction between P-gp and Bcl-x L and the effect of the selective silencing of P-gp on cell survival. P-gp and Bcl-xl expression was evaluated by immunohistochemistry on 28 spontaneously abortive human fetuses, 66 Hp-negative subjects, 138 Hp-positive chronic gastritis (CG) of whom 28 with intestinal metaplasia (IM) and 45 intestinal type GCs. P-gp/Bcl-x L colocalization was investigated by confocal immunofluorescence microscopy and protein-protein interaction by co-immunoprecipitation, in basal conditions and after stress-induced apoptosis, in GC cell lines AGS and MKN-28 and hepatocellular carcinoma cell line Hep-G2. The role of P-gp in controlling apoptosis was evaluated by knocking down its expression with a specific small interfering RNAs in stressed AGS and MKN-28 cell lines. P-gp is expressed in the gastric mucosa of all human fetuses while, it is undetectable in adult normal mucosa and re-expressed in 30/110 Hp-positive non-IM-CG, 28/28 IM-CG and 40/45 GCs. P-gp expression directly correlates with that of Bcl-x L and with the promoter hypomethylation of the MDR1 gene. In GC cell lines, P-gp is localized on the plasma membrane and mitochondria where it colocalizes with Bcl-x L. Co-immunoprecipitation confirms the physical interaction between P-gp and Bcl-x L in AGS, MKN-28 and Hep-G2, at both basal level and after stress-induced apoptosis. The selective silencing of P-gp sensitizes GC cells to stress-induced apoptosis. P-gp behaves as an oncofetal protein that, by cross-talking with Bcl-x L, acts as an anti-apoptotic agent in Hp-related gastric carcinogenesis.",
keywords = "apoptosis, gastric carcinogenesis, H. pylori, P-glycoprotein, stomach morphogenesis",
author = "Alba Rocco and Debora Compare and Eleonora Liguori and Alessandra Cianflone and Giuseppe Pirozzi and Virginia Tirino and Alessandra Bertoni and Margherita Santoriello and Corrado Garbi and Maria D'Armiento and Stefania Staibano and Gerardo Nardone",
year = "2012",
month = "10",
doi = "10.1038/labinvest.2012.100",
language = "English",
volume = "92",
pages = "1407--1418",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells

AU - Rocco, Alba

AU - Compare, Debora

AU - Liguori, Eleonora

AU - Cianflone, Alessandra

AU - Pirozzi, Giuseppe

AU - Tirino, Virginia

AU - Bertoni, Alessandra

AU - Santoriello, Margherita

AU - Garbi, Corrado

AU - D'Armiento, Maria

AU - Staibano, Stefania

AU - Nardone, Gerardo

PY - 2012/10

Y1 - 2012/10

N2 - P-glycoprotein (P-gp), traditionally linked to cancer poor prognosis and multidrug resistance, is undetectable in normal gastric mucosa and overexpressed in gastric cancer (GC). We propose that P-gp may be involved in Helicobacter pylori (Hp)-related gastric carcinogenesis by inhibiting apoptosis. Aim of the study was to evaluate the expression of P-gp in fetal stomach and in Hp-related gastric carcinogenesis, the epigenetic control of the multi-drug resistance-1 (MDR1) gene, the localization and interaction between P-gp and Bcl-x L and the effect of the selective silencing of P-gp on cell survival. P-gp and Bcl-xl expression was evaluated by immunohistochemistry on 28 spontaneously abortive human fetuses, 66 Hp-negative subjects, 138 Hp-positive chronic gastritis (CG) of whom 28 with intestinal metaplasia (IM) and 45 intestinal type GCs. P-gp/Bcl-x L colocalization was investigated by confocal immunofluorescence microscopy and protein-protein interaction by co-immunoprecipitation, in basal conditions and after stress-induced apoptosis, in GC cell lines AGS and MKN-28 and hepatocellular carcinoma cell line Hep-G2. The role of P-gp in controlling apoptosis was evaluated by knocking down its expression with a specific small interfering RNAs in stressed AGS and MKN-28 cell lines. P-gp is expressed in the gastric mucosa of all human fetuses while, it is undetectable in adult normal mucosa and re-expressed in 30/110 Hp-positive non-IM-CG, 28/28 IM-CG and 40/45 GCs. P-gp expression directly correlates with that of Bcl-x L and with the promoter hypomethylation of the MDR1 gene. In GC cell lines, P-gp is localized on the plasma membrane and mitochondria where it colocalizes with Bcl-x L. Co-immunoprecipitation confirms the physical interaction between P-gp and Bcl-x L in AGS, MKN-28 and Hep-G2, at both basal level and after stress-induced apoptosis. The selective silencing of P-gp sensitizes GC cells to stress-induced apoptosis. P-gp behaves as an oncofetal protein that, by cross-talking with Bcl-x L, acts as an anti-apoptotic agent in Hp-related gastric carcinogenesis.

AB - P-glycoprotein (P-gp), traditionally linked to cancer poor prognosis and multidrug resistance, is undetectable in normal gastric mucosa and overexpressed in gastric cancer (GC). We propose that P-gp may be involved in Helicobacter pylori (Hp)-related gastric carcinogenesis by inhibiting apoptosis. Aim of the study was to evaluate the expression of P-gp in fetal stomach and in Hp-related gastric carcinogenesis, the epigenetic control of the multi-drug resistance-1 (MDR1) gene, the localization and interaction between P-gp and Bcl-x L and the effect of the selective silencing of P-gp on cell survival. P-gp and Bcl-xl expression was evaluated by immunohistochemistry on 28 spontaneously abortive human fetuses, 66 Hp-negative subjects, 138 Hp-positive chronic gastritis (CG) of whom 28 with intestinal metaplasia (IM) and 45 intestinal type GCs. P-gp/Bcl-x L colocalization was investigated by confocal immunofluorescence microscopy and protein-protein interaction by co-immunoprecipitation, in basal conditions and after stress-induced apoptosis, in GC cell lines AGS and MKN-28 and hepatocellular carcinoma cell line Hep-G2. The role of P-gp in controlling apoptosis was evaluated by knocking down its expression with a specific small interfering RNAs in stressed AGS and MKN-28 cell lines. P-gp is expressed in the gastric mucosa of all human fetuses while, it is undetectable in adult normal mucosa and re-expressed in 30/110 Hp-positive non-IM-CG, 28/28 IM-CG and 40/45 GCs. P-gp expression directly correlates with that of Bcl-x L and with the promoter hypomethylation of the MDR1 gene. In GC cell lines, P-gp is localized on the plasma membrane and mitochondria where it colocalizes with Bcl-x L. Co-immunoprecipitation confirms the physical interaction between P-gp and Bcl-x L in AGS, MKN-28 and Hep-G2, at both basal level and after stress-induced apoptosis. The selective silencing of P-gp sensitizes GC cells to stress-induced apoptosis. P-gp behaves as an oncofetal protein that, by cross-talking with Bcl-x L, acts as an anti-apoptotic agent in Hp-related gastric carcinogenesis.

KW - apoptosis

KW - gastric carcinogenesis

KW - H. pylori

KW - P-glycoprotein

KW - stomach morphogenesis

UR - http://www.scopus.com/inward/record.url?scp=84866862182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866862182&partnerID=8YFLogxK

U2 - 10.1038/labinvest.2012.100

DO - 10.1038/labinvest.2012.100

M3 - Article

C2 - 22751348

AN - SCOPUS:84866862182

VL - 92

SP - 1407

EP - 1418

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 10

ER -